Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Galen Biotechnologies LLC
Profile last edited on: 3/28/16      CAGE: 54Q43      UEI:

Business Identifier: Drug discovery
Year Founded
2013
First Award
2014
Latest Award
2015
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

136 Sinsheimer Labs
Santa Cruz, CA 95060
   (650) 888-6329
   admin@galenbiotech.com
   www.galenbiotech.com/
Location: Single
Congr. District: 18
County: Santa Cruz

Public Profile

Galen Biotechnologies, LLC discovers and develops potent and selective small molecule drugs by radically reengineering ribosomal translation. The firm's Biologically Inspired-Chemically Designed Molecules combine the strengths of encoded biological library diversity with small molecule pharmacophores for rapid discovery and design of lead candidate therapeutics. This new platform will enable the rapid and systematic exploration of drug candidates against ‘undruggable’ therapeutic targe

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
1
Conversion Rate
50.00%
Phase I Dollars
$361,354
Phase II Dollars
$64,313
Total Awarded
$425,667

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2015 2 NIH $257,254
Project Title: Genetically Encoded Fragment-Based Drug Discovery
2014 1 NIH $168,413
Project Title: Cell-Free Synthesis of Site-specific Phosphothreonine Proteins

Key People / Management

  Christopher Murray

Company News

There are no news available.